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Abstract
Infections caused by multidrug resistant (MDR) bacteria are a major concern worldwide.
Changes in membrane permeability, including decreased influx and/or increased efflux of
antibiotics, are known as key contributors of bacterial MDR. Therefore, it is of critical impor-
tance to understand molecular mechanisms that link membrane permeability to MDR in
order to design new antimicrobial strategies. In this work, we describe genotype-phenotype
correlations in Enterobacter aerogenes, a clinically problematic and antibiotic resistant bac-
terium. To do this, series of clinical isolates have been periodically collected from two
patients during chemotherapy with imipenem. The isolates exhibited different levels of resis-
tance towards multiple classes of antibiotics, consistently with the presence or the absence
of porins and efflux pumps. Transport assays were used to characterize membrane perme-
ability defects. Simultaneous genome-wide analysis allowed the identification of putative
mutations responsible for MDR. The genome of the imipenem-susceptible isolate G7 was
sequenced to closure and used as a reference for comparative genomics. This approach
uncovered several loci that were specifically mutated in MDR isolates and whose products
are known to control membrane permeability. These were omp35 and omp36, encoding the
two major porins; rob, encoding a global AraC-type transcriptional activator; cpxA, phoQ
and pmrB, encoding sensor kinases of the CpxRA, PhoPQ and PmrAB two-component reg-
ulatory systems, respectively. This report provides a comprehensive analysis of membrane
alterations relative to mutational steps in the evolution of MDR of a recognized nosocomial
pathogen.
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Introduction
Multidrug resistance (MDR) is a significant problem for treatment of bacterial infections
worldwide. Although carbapenems are the last β-lactams that retain a nearly-universal activity
against Gram-negative bacteria, carbapenem-resistant Enterobacteriaceae (CRE) have emerged
as important cause of morbidity and mortality among hospital-acquired and long-term care-
associated infections. A 2013 report on antibiotic resistance threats by the American Centers
for Disease Control and Prevention (CDC) estimated that 730,000 infections and 3,400 deaths
were caused annually by CRE in the US alone [1]. This report also classified CRE as an urgent
threat. Therefore, it is of critical importance to understand the molecular mechanisms underly-
ing the emergence of MDR and to develop therapeutic alternatives for these problematic
bacteria.
Enterobacter aerogenes is one of the most common CRE together with Klebsiella pneumo-
niae and Escherichia coli. Since the early 1990s, E. aerogenes has emerged as an important
MDR pathogen, responsible for nosocomial infections, including respiratory and urinary tracts
infections, bacteremia, sepsis and post-chirurgical infections [2–4]. The emergence of MDR
strains of E. aerogenes is closely related to the clinical use of broad-spectrum β-lactams and car-
bapenems [5–10]. Several mechanisms account for MDR, including carbapenem resistance, in
this species. Resistance to β-lactams is mainly due to enzymatic degradation by a chromosomal
cephalosporinase, plasmid-mediated broad spectrum β-lactamases, and recently acquired car-
bapenemases [4, 6, 7, 9–14]. Changes in the bacterial cell envelope are also a key contributor to
the high levels of resistance towards β-lactams, including carbapenems, and other antibiotic
families such as fluoroquinolones [6–10, 12, 15–18]. These changes include quantitative or
qualitative modifications of outer membrane porins [6–10, 16, 18–20], and increased levels of
efflux pumps [12, 17, 18, 21, 22]. In Enterobacteriaceae, MDR is controlled by several regula-
tory genes and external factors [15]. MarA, RamA and SoxS are among the best studied MDR
regulators. Several mutations have been identified inmarRAB, ramAR or soxRS in clinical iso-
lates and associated to MDR [15]. These master regulatory pathways are interconnected and
function by up-regulating the expression efflux proteins and down-regulating the expression of
porins. In addition, MDR can be induced by clinically used antibiotics such as imipenem. This
phenomenon has been observed in vitro, when bacteria are trained to grow in the presence of
increasing concentrations of drugs and, in vivo, during antibiotic treatment of infected patients
[6–10, 21, 23]. Imipenem and others effectors probably act by activating MDR regulators such
as MarA or RamA.
So far, the vast majority of studies on clinical isolates were aimed to identify mutations in
the currently known resistance-conferring targets (i.e. promoter or structural mutations in
porin genes and mutations in local or global MDR regulatory genes) [24–28]. This approach is
biased in that some MDR isolates have no detectable alterations in any of these targets, suggest-
ing that other loci are involved in MDR that have yet to be identified. In addition, clinical iso-
lates are often collected from multiple patients after a local outbreak or obtained from human
infections at diverse geographic locations. This approach does not allow the identification of
steps of the in vivo evolution of drug resistance. We have previously reported the emergence of
MDR in E. aerogenes isolates recovered from several patients during their clinical course in
French hospitals [7]. All isolates were isogenic as indicated by randomly amplified polymor-
phic DNA (RAPD) genotyping and belonged to a prevalent epidemiologic clone that contains
a plasmid encoding a TEM-24 extended-spectrum β-lactamase (ESBL). Treatments with imi-
penem lead to MDR phenotypes associated to outer membrane permeability defects. Yet, virtu-
ally nothing was known about how these resistance traits were acquired. In this work, we
selected series of clinical isolates obtained from two patients infected with E. aerogenes. Five
Comparative Genomics of E. aerogenes Clinical Isolates
PLOS ONE | DOI:10.1371/journal.pone.0138828 September 23, 2015 2 / 19
Innovative Medicines Initiatives Joint Undertaking
under Grant Agreement n°115525, resources which
are composed of financial contribution from the
European Union’s seventh framework program (FP7/
2007-2013) and EFPIA companies in kind
contribution. This work was also supported by Aix-
Marseille Université and Service de Santé des
Armées. The authorhs assert that the funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The research leading to these
results was conducted as part of the
TRANSLOCATION consortium and has received
support from the Innovative Medicines Initiatives Joint
Undertaking under Grant Agreement n°115525,
resources which are composed of financial
contribution from the European Union’s seventh
framework program (FP7/2007-2013) and EFPIA
companies in kind contribution. This work was also
supported by Aix-Marseille Université and Service de
Santé des Armées. There are no patents, products in
development or marketed products to declare. This
does not alter the authors' adherence to all the PLOS
ONE policies on sharing data and materials, as
detailed online in the guide for authors.
isolates from patient P and seven isolates from patient G, covering the entire treatment period,
were phenotypically characterized and submitted to whole-genome sequencing. This approach
uncovered genetic determinants of resistance in E. aerogenes, which are all involved in outer
membrane permeability control. These results led to the identification of promising targets for
the development of drugs that would function as chemosensitizers to potentiate uptake and
activity of existing antibiotics.
Materials and Methods
E. aerogenes strains, growth media, antibiotics and chemicals
The two series of E. aerogenes isolates came from two patients hospitalized in 1997 and were
obtained from two different healthcare facilities in the south of France [7] (see S1 Table for
sampling sites). Patient P was treated with imipenem and four isolates have been recovered (P1
to P4). Patient G was treated with imipenem and cefpirome, and 7 isolates have been recovered
(G1 to G7). All strains were primarily isolated on Mueller Hinton (MH) agar. Because P4 con-
stantly gave rise to heterogeneous colonies after overnight growth at 37°C, we decided to
include both small and big colonies in our study. These will be hereafter referred to as P4 and
P5, respectively. We selected G7 as a representative E. aerogenes isolate for de novo sequencing
and comparative genome analysis based upon its susceptibility to imipenem (see S1 Table for
detailed susceptibility profiles). E. aerogenes ATCC13048 (KCTC2190) [29] and ATCC15038
are from our laboratory stock and were used as antibiotic susceptible strains. Unless indicated
otherwise, all strains were routinely cultured in Luria Bertani (LB) broth at 37°C with aeration.
All media were purchased from Difco Laboratories. Antibiotics and chemicals are from Sigma.
Determination of minimal inhibitory concentrations
Minimal inhibitory concentrations (MICs) were determined by broth dilution method in
96-wells microplates (Greiner Bio-One). Bacteria were cultured to exponential phase in cation
adjusted MH II broth. Approximately 2×105 colony forming units (CFU) were inoculated into
200 μL of fresh medium containing two-fold serial dilutions of each antibiotic in the absence or
in the presence of additive compounds: polymyxin B nonapeptide (PMBN), phenylalanine
arginine β-naphthylamide (PAβN), 1-(1-Naphtyl Methyl)-piperazine (NMP), EDTA, or clavu-
lanic acid. PMBN was used as a membrane permeabilizer at a final concentration of 102.4 μg/
ml. PAβN and NMP were used as efflux inhibitors at a final concentration of 20 μg/ml and
100 μg/ml, respectively. EDTA was added at a final concentration of 0.5 mM and used as a che-
lator of divalent cations to disturb the stability of lipopolysaccharide (LPS). Clavulanic acid
was added at a final concentration of 4 μg/ml and used as a β-lactamase inhibitor. After an
incubation of 18 h at 37°C, bacterial growth was evaluated by using 2-(4-iodophenyl)-3-
(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride as a viability dye. MICs were determined as
the lowest concentration of each antibiotic that prevented growth. Values are means of at least
three independent experiments and are expressed in μg/ml. Isolates were classified as suscepti-
ble (S), intermediate (I) or resistant (R) to the antibiotics tested according to the recommenda-
tions of the Antibiogram Committee of the French Society for Microbiology (http://www.sfm-
microbiologie.org).
Hoechst 33342 influx assays
Hoechst 33342 (H33342) was used as a fluorescent probe for permeability of the outer mem-
brane bilayer. All strains were cultured LB broth until they reached an OD600 between 1.8 and
2.4. Cells were harvested by centrifugation at room temperature, washed once and resuspended
Comparative Genomics of E. aerogenes Clinical Isolates
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in potassium phosphate buffer (PPB) (20 mM K2HPO4, pH 7.0) in the presence of 50 μM car-
bonyl cyanidem-chlorophenylhydrazone (CCCP) to an OD600 of 0.4. 100 μl of bacterial sus-
pensions were transferred in black flat bottom 96 well half area microplates (Greiner Bio-One).
H33342 was added to the mixtures at a final concentration of 5 μM and the fluorescence of the
H33342 bound to nucleic acids generated by the influx of H33342 into the cells was determined
at room temperature by using an Infinite1M200 Pro (TECAN) spectrofluorometer with exci-
tation and emission wavelengths of 360 and 500 nm, respectively. CCCP was used to collapse
the protonmotive force (pmf) across the inner membrane. Slopes resulting from the initial
increase in H33342 fluorescence were calculated and expressed as changes in fluorescence
intensity per second (ΔFI/s). Total accumulation levels were calculated as areas under the
curves. All values are means of at least three independent experiments.
Fleroxacin accumulation
All strains were cultured overnight in LB broth until they reached an OD600 of 0.6. Cells were
harvested by centrifugation, washed once and concentrated 10-fold in 50 mMNaPi pH 7.0
supplemented with 5 mMMgCl2 to approximately 10
10 CFU/ml. Zero-time samples were
removed and fleroxacin was added to a final concentration of 64 μg/ml in the absence or in the
presence of 10 μM of CCCP. An incubation of 30 min at 37°C was chosen based on preliminary
kinetic experiments to reach saturation (data not shown). 0.8 ml aliquots were then removed,
loaded onto a 1.1 ml cushion of 1 M sucrose and immediately centrifuged for 5 min at 4°C. The
pellets were resuspended in 0.5 ml of 0.1 M Glycin-HCl pH 3.0 and incubated for 2 h at room
temperature to lyse the cells. The lysates were centrifuged for 15 min at 4°C to remove any cell
debris and 100 μl-aliquots of the supernatants were transferred in black flat bottom 96 well half
area microplates. Spectra were recorded by using an Infinite1M200 Pro (TECAN) spectroflu-
orometer with excitation and emission wavelengths of 290 nm and 310–700 nm, respectively.
The concentration of fleroxacin in the supernatants was estimated after normalization of the
spectra to their corresponding tryptophan emission peak at 356 nm. The antibiotic-free control
was subtracted from the values obtained for each assay. All values are means of at least three
independent experiments.
1,2’-dinaphthylamine efflux assays
The procedure for real-time efflux assays of 1,2’-dinaphthylamine (1,2’-DNA) was adapted
from Bohnert et al. [30]. Briefly, all strains were cultured overnight in MH II at 37°C. Cells
were harvested by centrifugation, washed once and resuspended in PPB supplemented with
1 mMMgCl2 (Mg-PPB) to a final OD600 of 0.25. Cells were first deenergized by an overnight
incubation in Mg-PPB with 5 μMCCCP and loaded with 32 μM 1,2’-DNA at 37°C in the dark.
Cells were then centrifuged, washed, resuspended in Mg-PPB and 100 μl of bacterial suspen-
sions were transferred in black flat bottom 96 well half area microplates. Fluorescence was fol-
lowed over 60 sec and 1,2’-DNA efflux was triggered after rapid reenergization with 5 μl of 1 M
glucose and monitored for another 250 sec. All measurements were performed at 37°C by
using an Infinite1M200 Pro (TECAN) spectrofluorometer with excitation and emission wave-
lengths of 370 nm and 420 nm, respectively. Slopes resulting from the initial decrease in 1,2’
DNA fluorescence were calculated and expressed as changes in fluorescence intensity per sec-
ond (ΔFI/s). Values are means of at least three independent experiments.
Protein methods
All strains were cultured overnight at 37°C in MH broth. Aliquots of cells were harvested by
centrifugation and resuspended in Laemmli sample buffer to an OD600 of 2.0. After 5 min at
Comparative Genomics of E. aerogenes Clinical Isolates
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95°C, protein samples (10 μl* 0.2 OD units) were run on polyacrylamide 10% mini gels and
transferred onto nitrocellulose membranes. Membranes were probed with primary antibodies
raised against Escherichia coli OmpF (1:5,000), OmpC (1:5,000), AcrA (1:10,000), AcrB
(1:2,000) or TolC (1:2,000). Goat anti-rabbit horseradish-peroxydase conjugated immunoglob-
ulin G secondary antibodies and a chemiluminescent kit (BioRad) were used for detection.
Outer membrane porins were identified and characterized by mass spectrometry. Briefly,
strains were cultured overnight in osmotically-controlled media—Nutrient broth (NB, 46(±3)
mOsmol/kg) and NB supplemented with 20% sorbitol (NBS, 1290(±23) mOsmol/kg)—, in
which the porin ratio is tightly regulated. Cell pellets from 100 ml cultures were washed once
and resuspended in 3 ml lysis buffer containing 20 mM Tris-HCl, pH 7.5 and 1 mMMgCl2.
Bacterial cells were broken by one passage through cell disrupter at 2 kBars. Unlysed cells were
removed by centrifugation (8,000 × g for 20 min) and supernatant was ultracentrifuged at
105,000 × g for 1 h. Pellets containing whole cell-envelope were mixed with Laemmli sample
buffer, heated for 5 min at 95°C, and membrane proteins were separated by SDS-PAGE. Urea
(4 M) was added to the SDS-polyacrylamide running gel in order to better resolve Omp35 and
Omp36. Bands of interest were excised, digested with trypsin, and analyzed by Nano-LC MS/
MS at the SICaPs (Imagif, Service d’identification et de caractérisation des protéines par spec-
trométrie de masse, Plateforme SICaPS, Campus CNRS, Gif-sur-Yvette).
E. aerogenesG7 de novo DNA sequencing and assembly
Total DNA of E. aerogenes G7 was isolated from an overnight culture using the Wizard1
Genomic DNA Purification Kit (Promega) according to the manufacturer’s instructions,
except for the following modifications. During the protein precipitation step, the samples were
incubated on ice for 10 min and centrifuged for 10 min at 4°C. The supernatants were recov-
ered and centrifuged again to carefully eliminate any precipitates and to ensure an optimal
DNA quality for sequencing. Total DNA was qualitatively and quantitatively checked by
migration on agarose gels and by using a NanoDrop™ spectrophotometer. The genome of G7
was sequenced de novo on PacBio RS, assembled and annotated by GATC Biotech AG
(Cologne, Germany). Genome annotation was performed with Glimmer 3 [31] and RAST
(http://rast.nmpdr.org/) [32, 33]. The genome of EAG7 has been deposited in GenBank under
National Center for Biotechnology Information (NCBI) accession numbers CP011539 (EAG7
chromosome) and CP011540 (EAG7 plasmid pGPN1).
Genome sequencing of the E. aerogenes isolates and detection of
variations
Total DNA was isolated from overnight cultures of the twelve E. aerogenes isolates, including
G7, as described above. Genomes were sequenced by using an Illumina HiSeq 2000 sequencer
(100 bp paired end) and HiSeq reads were mapped to the G7 assembled genome by GATC
using BWA [34] with the default parameters. SNPs and InDels were called using GATK's Uni-
fiedGenotyper. All SNPs and InDels were individually checked in silico using the Tablet soft-
ware [35], to eliminate GATK’s false positives. SNPs and InDels that lead to modifications of
predicted coding sequences and that were specifically present in resistant isolates were con-
firmed by PCR and sequencing (Eurofins, MWG, Ebersberg, Germany). HiSeq reads that
could not be mapped to the PacBio assembled genome of G7 were considered as regions of
divergence. Genome assembly from the HiSeq data was first performed by using Velvet 1.2.10
[36] and resulted in several contigs for each isolate. The contigs of the twelve genomes were
then aligned relative to the assembled genome of G7 and compared with progressiveMauve
[37]. Specific sequences from each strain were isolated and analyzed by blastn [38]. Phage-
Comparative Genomics of E. aerogenes Clinical Isolates
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related sequences were searched by using PHAST (http://phast.wishartlab.com) [39]. Insertion
sequences (IS) were characterized by using the ISFinder database (http://www-is.biotoul.fr)
[40]. Putative integrative conjugative elements (ICEs) and integrative mobilizable element
(IMEs) were found by performing iterative similarity searches followed by protein clustering.
With this approach, ICEs would correspond to recombinase/integrase-bounded regions con-
taining type IV secretion system (T4SS) proteins and MobA-type relaxase(s), while IMEs
would comprise relaxase(s) with no neighbor T4SS. Metadata were deposited in the NCBI
Sequence Read Archive under the accession SRP056584.
Results
Clinical isolates and evolution of antibiotic resistance
Patient P was hospitalized without any sign of infection. However, the patient was immuno-
compromised and rapidly developed a respiratory tract infection associated to E. aerogenes.
Isolate P1 corresponded to the first isolation of E. aerogenes from a bronchial aspirate and was
susceptible to almost all tested antibiotics including gentamicin (data not shown), carbape-
nems, third (ceftazidime and cefotaxime) and fourth (cefepime) generation cephalosporins,
and quinolones (Table 1 and S1 Table for detailed MIC values). From that point, patient P was
treated with imipenem. Four days after the first use of imipenem, P2 was isolated from a new
bronchial aspirate. Although this strain still retained susceptibility to gentamicin, it was fully
resistant to quinolones, carbapenems and cephalosporins. The last strains P4 and P5, isolated
after twelve days of treatment, presented the same MDR phenotype. Interestingly, the mid-
term isolate P3 was resistant to quinolones but susceptible to carbapenems, suggesting the co-
existence of two subpopulations at day 4.
Patient G was hospitalized in an intensive care unit in a different geographic zone. The first
strain of E. aerogenes was isolated from the urinary tract three months after hospitalization.
Isolate G1 was susceptible to gentamicin, carbapenems and cephalosporins but resistant to flu-
oroquinolones. After four weeks of treatment with imipenem, E. aerogenes disappeared from
the urinary tract, but reappeared as a MDR strain in the vaginal tract (isolate G2). From that
point, treatment was stopped for one month. During this period, isolates G3 and G4 were cul-
tured from sputum and vagina, respectively, and showed a reversion of resistance to carbape-
nems. Patient G finally received cefpirome for a few days and imipenem for two weeks. Isolates
G5 and G6 were cultured from vagina and blood at the end of this period, and both showed
similar MDR phenotypes. Three weeks after imipenem treatment was stopped, isolate G7 was
cultured from a bronchial aspirate, with a new reversion of susceptibility to carbapenems.
Membrane permeability and efflux activity in the E. aerogenes isolates
Outer membrane porins represent the unique specific route of the uptake of β-lactam antibiot-
ics [16]. Therefore, porin expression levels in the isolates were analyzed by western-blot using
antibodies directed against denatured E. coli OmpF and OmpC (data not shown). Reference
strains ATCC13048 and ATCC15038 were included as controls, as the former expresses only
Omp36 (OmpC) and the latter expresses both Omp36 and Omp35 (OmpF). One cross-react-
ing band was detected in carbapenem-susceptible strains only. This band was identified as
Omp36 by mass spectrometry (S1 Fig and S2 Table).
To examine outer membrane permeability, intact bacterial cells were incubated with
H33342. Once H33342 crosses the outer membrane, it diffuses through the inner membrane
very rapidly and binds to nucleic acids in the cytoplasm, producing a fluorescent signal. Thus,
one can determine the rate-limiting step (i.e. the influx across the outer membrane) from the
rate of fluorescence increase. H33342 is a large (> 12 Å across), hydrophobic dye, with
Comparative Genomics of E. aerogenes Clinical Isolates
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delocalized positive charges, thus unlikely able to diffuse through the narrow porin channel.
Resuspension of cells in divalent cation-free buffer was expected to destabilize the LPS leaflet of
the outer membrane and active efflux was blocked by the presence of the pmf inhibitor CCCP.
When H33342 total accumulation levels and entry rates were compared, all strains showed
similar permeability, although slightly lower to that of the reference strain ATCC15038 (Fig 1
and S3 Table). This result suggests the absence of major remodeling processes that would
account for outer membrane impermeability in the isolates. Nevertheless, it is important to
note that this assay does not reflect porin alterations.
A common characteristic of the MDR isolates of E. aerogenes is their high level of resistance
towards quinolones (Table 1 and S1 Table). Hence, we used a fluorometric assay based on
determination of the time course accumulation of a fluoroquinolone inside the cells to assess
efflux [41]. Fig 2 shows the intracellular accumulation of fleroxacin in the E. aerogenes isolates.
Higher accumulation was observed in the presence of CCCP, confirming the presence of an
active efflux in all the strains. Of note, MDR isolates from patient P—P2, P4 and P5—showed a
more than 2-fold accumulation of fleroxacin in the presence of CCCP (Fig 2). However, accu-
mulation levels in the different isolates could not be related to the presence or the absence of
outer membrane porins. This could be explained by the fact that membrane permeability plays
only a secondary role in quinolone uptake, in sharp contrast to other antibiotics such as β-
lactams.
Fig 1. Hoechst 33342 influx into E. aerogenes strains. Strains were grown in LB broth and cells were harvested at the beginning of the stationary phase.
Cells were washed, resuspended in PPB pH 7.0, and the H33342 influx was assayed in the presence of 50 μMCCCP. A. Chemical structure of H33342. B.
Kinetics of H33342 influx. AU, arbitrary units. C. Total accumulation in E. aerogenes isolates after normalization to that of strain ATCC15038. All values are
means of at least three independent experiments.
doi:10.1371/journal.pone.0138828.g001
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We also used a real-time efflux assay with cells that have been preloaded with the fluores-
cent dye 1,2'-DNA. Consistently with previous results, isolates from patient P display higher
efflux rates in comparison to ATCC15038 and isolates from patient G (with the exceptions of
G1 and G5) (Fig 3 and S3 Table).
Genomic features of E. aerogenesG7 and others clinical isolates
In order to identify putative mutations that could account for porin regulation all twelve E.
aerogenes isolates were submitted to whole-genome sequencing and mapped to G7, selected as
Fig 2. Fleroxacin accumulation in E. aerogenes strains. Strains were grown in LB broth and cells were
harvested at mid-log phase. Cells were washed and concentrated 10-fold in NaPi pH 7.0 supplemented with
Mg2+. Fleroxacin (FLX) was added to the bacterial suspensions in the absence or in the presence of 10 μM
CCCP. After a 30 min incubation time, bacterial lysates were prepared as described in Materials and
Methods. The concentration of FLX in the lysates was estimated after normalization of the spectra to their
corresponding tryptophan emission peak at 356 nm. The antibiotic-free control time-zero was subtracted from
the values obtained for each assay. All values are means of at least three independent experiments.
doi:10.1371/journal.pone.0138828.g002
Fig 3. Real-time efflux of 1,2'-DNA in E. aerogenes strains. Strains were grown in LB broth for 24 h at 37°C and cells were harvested by centrifugation.
Cells were deenergized by an overnight incubation in Mg-PPB pH 7.0 with 5 μMCCCP and loaded with 1,2’-DNA. Cells were then washed, resuspended in
Mg-PPB pH 7.0 and 1,2’-DNA efflux was monitored after rapid reenergization with glucose. RFU, relative fluorescence units. All values are means of at least
three independent experiments.
doi:10.1371/journal.pone.0138828.g003
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a representative E. aerogenes isolate, as describes in Materials and Methods. The average depth
of coverage for the twelve isolates was 388-fold, and over 95% of the newly sequenced and
assembled E. aerogenes G7 genome was covered after mapping (Table 2).
The genome of E. aerogenes G7 (EAG7) includes a chromosome of 5,452,368 bp with a GC
content of 54.92% and 2 plasmids: a large plasmid of 174,066 bp (pGPN1) and a smaller plas-
mid of 25,284 bp (pGPN2), from which we only obtained a partial sequence of about 9 Kbp but
was likely identical to pNJS258C2 found in a carbapenem-resistant clinical isolate of K. pneu-
moniae [42] (Fig 4 and S1 Dataset). These two plasmids were present in all the sequenced
strains and contained multiple antibiotic resistance markers, including blaTEM-24 on pGPN1
(see S3 Dataset for a complete list). Isolates P2 to P5 have a third plasmid of 34,826 bp similar
to pN-Cit found in Citrobacter freundii strain CFSTE [43]. The functional annotation of the
Table 2. Summary of genome analysis.
Isolate P2-P5 G1 G2-G6
Coverage (% to the reference strain after mapping) Chromosome pGPN1 98.2 95.1 96.6 95.2 99.1 95.3
Reads (* % of mapped) 85 92 93
SNPs and InDels 70–72 92 7–11
doi:10.1371/journal.pone.0138828.t002
Fig 4. Genome of E. aerogenesG7. This figure was generated with GCviewer (http://stothard.afns.ualberta.ca/cgview_server/) and shows the map of the
chromosome and plasmid pGPN1 (174 Kbp) of E. aerogenes isolate G7 obtained by de novo sequencing and assembly.
doi:10.1371/journal.pone.0138828.g004
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chromosome indicates a total of 5,267 predicted coding sequences (CDSs) (Table 3). The G+C
content of the EAG7 chromosome is 54.92%, which is in agreement with values previously
reported for KCTC2190 (54.8%) [29] and EA1509E (55%) [44]. There were 8 ribosomal oper-
ons and 88 transfer RNAs (tRNAs) identified in EAG7, with 87 specific for the biosynthesis of
all the 20 standard amino acids and 1 for the selenomethionine biosynthesis, which was identi-
cal to those of EA1509E but different from KCTC2190 that carries a total of 109 structural
RNAs (Table 3 and S1 Dataset). Regarding the chromosome size, EAG7 resembles the “killer
bug” EA1509E, while the strain KCTC2190 presents a smaller chromosome size. This is proba-
bly due to the accumulation of genes related to their host-associated life-style and adaptation
under anti-microbial selective pressure. The E. aerogenes G7 chromosome also contains four
intact prophages, which differ from the genome of E. aerogenes KCTC2190, four IS elements,
and one ICE (Table 3, S2 Fig, S1 and S2 Datasets). Multiple genome alignments obtained by
progressiveMauve were used to compare the overall genome architecture of EAG7 to that of
other strains—including the genomes of the other isolates and the previously published
genomes of strains KCTC2190 and EA1509E [29, 44]. Some of these alignments are shown
supplementary information (S3 Fig). Overall, the E. aerogenes isolates appeared to be charac-
terized by a low degree of divergence and the genetic synteny among the chromosomes was
conserved. The alignment of EAG7 to EA1509E shows the existence of fourteen locally collin-
ear blocks (LCBs) of witch twelve correspond to the chromosome and to the large plasmid
pGPN1 (Figure A in S3 Fig). This analysis also indicates that the isolates can be separated into
distinct populations. Strains G2 to G7 have syntenic genomes with highly conserved sequences
and only one putative rearrangement located on pGPN1 (Figure C in S3 Fig: inversion of LCBs
2 and 3 relative to G7 genome). On the opposite, the genome of G1 exhibits more rearrange-
ments and modifications when compared to that of G7, thus indicating that G1 is more distant
Table 3. Features of the G7 genome. CDS, coding sequences; ICE, integrative and conjugative element;
IS, insertion sequence. *Data refer to the chromosome only, except when plasmids are indicated.
E. aerogenes G7 *
Size (bp) 5,452,368
GC content (%) 54.92
CDS (n) 5,267
rRNAs (n)
16S 8
23S 8
5S 9
tRNAs (n) 87
Plasmids (n) 2
Prophages (n) 8
PhageG7.1 Intact
PhageG7.2 Intact
PhageG7.3 Questionable
PhageG7.4 Intact
PhageG7.5 Incomplete
PhageG7.6 Questionable
PhageG7.7 Intact
PhageG7.8 Questionable
ICEs (n) 1
IS elements (n) 4
IS5075 3
IS1351 1
doi:10.1371/journal.pone.0138828.t003
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to G7 than the other G isolates (Figure B in S3 Fig). These modifications include the absence of
three regions of 42–48 Kbp associated with phage functions and nearly 103 Kbp of additional
sequences (S2 Fig, S1 and S2 Datasets). Strains P2 to P5 also present genome rearrangements
and modifications compared to G7 (Figure E in S3 Fig). Among these, one prophage region of
48 Kbp was absent, around 98 Kbp of supplementary sequences, corresponding to the Imp
locus (involved in type VI secretion) and phage functions, and a supplementary plasmid of
about 35 Kbp, similar to pN-Cit from C. freundii strain CFSTE (S2 Dataset) were found. Pro-
gressiveMauve plots also show that isolate P1 is clearly distant from all the other isolates but
shares a good synteny with the reference strain KCTC2190 (Figure A in S3 Fig). For this rea-
son, isolate P1 was not further studied.
Comparative genomics between the clinical isolates and identification of
mutations associated to MDR
Comparative genome sequencing of all twelve isolates pointed to several mutations (see S2
Dataset for a complete list of SNPs and InDels). Total, we found 70–72 and 9–11 mutations in
the genome of isolates P2-P5 and G2-G6, as compared to that of G7, respectively. These values
confirm that the isolates are closely related. Interestingly, only a few numbers of non-synony-
mous mutations were specifically present in the core genome of MDR isolates. The QRDRs in
all twelve isolates, including gyrA, gyrB, parC and parE genes, contained several amino acid
substitutions (Ser67Ala and Thr83Ile in GyrA and Ser80Ile in ParC for isolates P2-P5 and G1;
Thr83Ile and Asp87Asn in GyrA and Ser80Ile in ParC for isolates G2-G7), when sequences
were compared to that of KCTC2190. These mutations likely explain quinolone resistance in
theses isolates (Table 1 and S1 Table). Additional mutations mapped to 6 loci that are known
to control outer membrane permeability. Frameshift mutations introducing stop codons in the
structural gene of Omp36 were systematically identified in all MDR isolates—P2, P4, P5, G2,
G5 and G6. Isolate G2 also carried a mutation in the structural gene of Omp35. Isolates P4-P5
and G5 contained non-synonymous mutations in regulatory genes: P4 and P5 were mutated in
cpxA (generating a Tyr144Asn substitution); an intergenic mutation between cpxP and cpxRA
was found in P5; G5 was mutated in rob (generating a Gly140Ser substitution), phoQ (generat-
ing a Leu348Gln substitution) and pmrB (generating a Thr157Pro substitution). Rob is a global
transcription factor of the AraC/XylS family. MarA, SoxS and Rob have been shown to func-
tion in co-operative manner to induce MDR in response to a variety of external stresses [45,
46]. CpxA, PhoQ and PmrB (BasS) are sensor kinases of the CpxRA, PhoPQ and PmrB
(BasRS) two-component regulatory systems, respectively. The CpxRA two-component system
has been extensively studied and reported as a major pathway for outer membrane stress
response [47]. Notably, activation of CpxRA down regulates the expression of outer membrane
proteins [48]. On the other hand, PhoPQ and PmrAB two-component systems control the
expression of LPS-modifying enzymes [49, 50]. These data now offer a unique opportunity to
study the influence of two-component regulatory systems on outer membrane permeability,
including porin expression and LPS modification, and MDR phenotypes in clinical isolates.
Nonetheless, the observation that these mutations appeared during imipenem chemotherapy
in parallel with the emergence of carbapenem-resistance strongly suggests that they provide an
adaptive response to the antibiotic stress.
Discussion
Carbapenem-resistant Enterobacteriaceae are considered as an urgent threat worldwide. A first
step to combat this threat is to understand the genomic traits of resistant clinical isolates as a
mean to get new insight into their successful adaptation as nosocomial pathogens. It is also
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important to consider the genome evolution of clinical strains isolated from patients at timed
intervals during antibiotic treatments. Herein, we performed whole genome sequencing
(WGS) on a total of twelve clinical strains of E. aerogenes isolated from two patients treated
with imipenem and showing variable MDR phenotypes. We have thoroughly mined the
genome of the imipenem-susceptible EAG7. Of note, as EA1509E and EAG7 both belong to a
same epidemic clone, we now have access to two completely determined and closed genomes
of E. aerogenes representatives involved in large hospital outbreaks in France. The genome of
EAG7 is composed of one chromosome and two plasmids of different sizes. It contains multi-
ple resistance markers, including β-lactamases and efflux pumps, which can contribute to the
successful adaptation of this strain to the hospital environment. WGS of the twelve isolates fol-
lowed by comparative genomics using EAG7 as a reference allowed us to determine the
genome evolution of the strains in the patient host and identify putative mutations responsible
for MDR (S2 and S3 Datasets). For patient P, isolate P1, which was found closely related to
KCTC2190, disappeared rapidly after the first use of imipenem. Analysis of SNPs in the P2-P5
isolates rather suggests the co-existence of an imipenem-susceptible ancestor resembling P3.
Then, constant exposure to antibiotic stress during the whole period of treatment fixed muta-
tions that occurred in a stepwise manner in this population in strict correlation with the acqui-
sition of new phenotypic resistances (Fig 5A). Likewise, isolate G1 did not evolve during
antibiotic treatment, suggesting the co-existence of an imipenem-susceptible ancestor that sub-
sequently yielded G2-G7. However, one cannot rule out the possibility of an exogenous infec-
tion. For patient G, discontinuity of the treatment lead to several genotypes associated to MDR
as well as genotypic-phenotypic reversions (Fig 5B). Notably, periods of imipenem treatment
induced porin-loss concomitant to carbapenem-resistance.
In this study, we used different assays to analyze and correlate the phenotypic and genotypic
characteristics of two series of E. aerogenes clinical isolates. We found no mutation in themar,
ram or sox region that could differentiate G7 from the other isolates. Only isolate G5 has a sin-
gle base pair exchange in rob that generates the amino acid substitution Gly140Ser in Rob. Pre-
vious results from an heterogeneous collection of our clinical isolates showed the presence of
multiple but conserved mutations in both ramA and ramR, when sequences were compared to
that of the reference strains ATCC15038 and ATCC13048 (A. Molitor, A.V. Davin-Régli and J.
M. Pagès, unpublished data). Isolates G6 and P2 were part of this collection. All had a 5 bp
deletion upstream of ramA, between the marbox and the translational start; 3 bp exchanges
that generated 3 amino acid substitutions (Ala72Asp, Pro100Ser and Ile121Ser) and a frame-
shift mutation that altered and shortened the C-terminus of RamR. Interestingly, q-PCR analy-
sis also showed these three isolates had increased levels of ramA and acrA transcripts, together
with decreased levels of omp35 transcripts, in comparison to the reference strains. However,
the impact of the mutated ramA or ramR on MDR and efflux pumps expression has not been
tested.
Our data suggest that both reduced outer membrane permeability and expression of β-lacta-
mases, but not efflux, are the main contributors of MDR in these isolates. Indeed, a previous
study showed that all twelve isolates belong to a prevalent epidemiologic clone that contains a
plasmid encoding a TEM-24 ESBL [7]. Moreover, the presence of an inducible chromosomal
AmpC β-lactamase has been detected in the isolates, with the exception of G1 (data not
shown). These data were confirmed by WGS and likely explain the high resistance levels to
cephalosporins even in the presence of a β-lactamase inhibitor (i.e. TEM-24 but not AmpC is
inhibited by clavulanic acid) (S1 Table). Here, it is also worth to note that the blaTEM-24 gene
located on pGPN1 is flanked sequences of ISSwi1, thus could be subject to duplication by
recombination between regions of homology (S1 Dataset). Gene duplications are relevant to
the evolution of resistance in that these events are frequent and instable.
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High resistance levels to quinolones are generally due to increased efflux activity and/or tar-
get mutations. Here, active efflux has been detected in all the isolates using fluorimetric assays
(Figs 2 and 3). However, the use efflux inhibitors such as PAβN or NMP did not restore suscep-
tibility to quinolones but only that of erythromycin (S1 Table). This strongly suggests the pres-
ence of mutations in QRDRs of DNA gyrase and/or topoisomerase IV subunits.
Although all the isolates produce β-lactamases, resistance to carbapenems is exclusively
related to the loss of Omp36. Consistently, susceptibility to β-lactams can only be restored by
the addition of PMBN, a derivative of polymyxin B that increases outer membrane permeabil-
ity and facilitates antibiotic permeation (S1 Table). The absence or the decreased expression of
the two major porins (OmpF and OmpC in E. coli, Omp35 and Omp36 in E. aerogenes or
OmpK35 and OmpK36 in K. pneumoniae) in combination with the presence of β-lactamases
has been previously implicated in carbapenem-resistance [4, 6–10, 23, 51]. Here, we found that
Fig 5. Model of intra-patient evolution of E. aerogenes during antibiotic treatment. Plain arrows
represent the putative evolution of bacterial subpopulations in patient P (A) and patient G (B). The genomic
distance between the first isolates (P1 and G1) and the subsequent strains (P2-P5 and G2-G7) indicates that
these have evolved from other ancestors (P0 and G0). Lack of evidence of genotypic reversion (Rev) from
resistant to susceptible strains within the G series suggest alternative evolutionary pathways represented by
dotted arrows. Clinical timelines are indicated from day (D) 1 to D12 and week (W) 1 to W13 for patient P and
patient G, respectively. IMI, imipenem; CEF, cefpirome.
doi:10.1371/journal.pone.0138828.g005
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none of the clinical isolates expressed Omp35 while Omp36 was only expressed in the carbape-
nem-susceptible strains. WGS data were used to investigate the basis of porin loss. In all cases,
the loss of Omp36 resulted from frameshift mutations in the coding sequence leading to a pre-
mature translational stop. In contrast, the loss of Omp35 is less clear, with the exception of iso-
late G2 in which omp35 is inactivated by a frameshift mutation (S2 and S3 Datasets). We
suspect molecular mechanisms working at the transcriptional or post-transcriptional level or
preventing porin insertion into the outer membrane. Part of this question will be addressed by
transcriptomic analysis.
Special attention will also be given to missense mutations that were identified in three differ-
ent sensor kinase two-component regulatory systems—cpxA in isolates P4-P5, and phoQ and
pmrB in isolate G5. Such mutations are not uncommon in bacteria and have been linked to
antimicrobial resistance [52–58]. Mutations in the cpxA have been shown to contribute to ami-
kacin and cephalosporin resistance in E. coli and Salmonella enterica serovar Typhimurium,
respectively [52]. Mutations in phoQ and pmrB have been identified in multiple pathogens
including S. enterica, P. aeruginosa and K. pneumoniae [53–58]. These two-component systems
control the expression of genes linked to LPS modification and promote resistance to polyca-
tionic antimicrobials, including polymyxins and antimicrobial peptides. Consistently, we
observed that isolate G5 shows high resistance level to polymyxin B (S1 Table). Future works
will aim to study the role of two-component systems in antibiotic resistance and examine these
systems as potential targets for the development of drugs to potentate uptake and activity of
existing antibiotics.
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